Does FDG PET-Assisted Management of Patients With Left Ventricular Dysfunction Improve Quality of Life? A Substudy of the PARR-2 Trial

2012 ◽  
Vol 28 (1) ◽  
pp. 54-61 ◽  
Author(s):  
Tushar Shukla ◽  
Graham Nichol ◽  
George Wells ◽  
Robert A. deKemp ◽  
Ross A. Davies ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Left Ventricular Dysfunction ◽  
Fdg Pet ◽  
Ventricular Dysfunction ◽  
Left Ventricular ◽  
Improve Quality ◽  
Assisted Management

scholarly journals The Left Ventricular Dysfunction Questionnaire: Italian translation and validation

2005 ◽  
Vol 64 (2) ◽  
Author(s):  
Daniela Miani ◽  
Dario Gregori ◽  
Marco Ghidina ◽  
Patrizia Rozbowsky ◽  
Laura Pilotto ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Heart Failure ◽  
Health Status ◽  
Left Ventricular Dysfunction ◽  
Ventricular Dysfunction ◽  
Nyha Class ◽  
Left Ventricular ◽  
Italian Version ◽  
Disease Specific

Patients affected by heart failure have a compromised quality of life (QOL) and in the last few years “health related quality of life” has become an important outcome indicator for the evaluation of heart failure treatment. Methods: Translation into Italian of the Left Ventricular Dysfunction Questionnaire (LVD-36), a new, 36-item, disease-specific health status instrument for patients with congestive heart failure, and its subsequent validation by administration to 50 consecutive patients in our heart failure outpatient clinic. The Italian LVD-36 was compared to the “The Minnesota Living with Heart Failure Questionnaire” (MLHF). Results: The Italian version of the LVD-36 correlates well with MLHF for ejection fraction (EF), NYHA class I and II, etiology and therapy. Since, however, the LVD-36 has only one domain, it may be able to offer more synthetic information than MLHF about patients’ status. Conclusions: The Italian version of the LVD-36 appears to be a reliable instrument for assessing patients’ QOL and the degree of limitations imposed on them by the disease. It is short, clear and easy to complete. In patients with heart failure the LVD-36 correlates well with the MLHF and may be considered a new disease- specific instrument to estimate changes in health status, and an useful support in optimizing therapeutic options.

Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial quality-of-life substudy

1993 ◽  
Vol 71 (12) ◽  
pp. 1069-1073 ◽  
Author(s):  
Larry Gorkin ◽  
Nancy K. Norvell ◽  
Raymond C. Rosen ◽  
Ed Charles ◽  
Sally A. Shumaker ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Left Ventricular Dysfunction ◽  
Ventricular Dysfunction ◽  
Left Ventricular ◽  
Baseline Data ◽  
Trial Quality

536 The effect of diuretics on peak oxygen consumption and quality of life in patients with compensated left ventricular dysfunction

2006 ◽  
Vol 5 (1) ◽  
pp. 117-117
Author(s):  
S GUPTA ◽  
C WAYWELL ◽  
P CLAYTON ◽  
N GANDHI ◽  
T COPPINGER ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Oxygen Consumption ◽  
Left Ventricular Dysfunction ◽  
Ventricular Dysfunction ◽  
Left Ventricular ◽  
Peak Oxygen Consumption

scholarly journals Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: The studies of left ventricular dysfunction

1994 ◽  
Vol 23 (2) ◽  
pp. 393-400 ◽  
Author(s):  
William J. Rogers ◽  
David E. Johnstone ◽  
Salim Yusuf ◽  
Debra H. Weiner ◽  
Philip Gallagher ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Left Ventricular Dysfunction ◽  
Ventricular Dysfunction ◽  
Left Ventricular

scholarly journals Assessment of Myocardial Viability: A Review of Current Non Invasive Imaging Techniques

2015 ◽  
Vol 1 (3) ◽  
pp. 113 ◽  
Author(s):  
Ahmed Talib
Keyword(s):  
Quality Of Life ◽  
Coronary Artery Disease ◽  
Ventricular Dysfunction ◽  
Imaging Techniques ◽  
Left Ventricular ◽  
Common Cause ◽  
Non Invasive ◽  
Artery Disease ◽  
Impaired Quality

Coronary artery disease (CAD) is the most prevalent and<br />single most common cause of morbidity and mortality1 with<br />the resulting left ventricular dysfunction (LVD) an important<br />complication2. Worldwide, CAD accounts for 5.7 million new<br />cases per year, of these 1.3 million in Europe alone3. In addition,<br />it imposes a substantial share of health service resources and<br />expenses, an impaired quality of life, disability and high social<br />cost3,4. Furthermore, LVD itself has been shown to be a powerful<br />determinant of survival2, 5.

Sign in / Sign up

Export Citation Format

Share Document